MARKET WIREYahoo • 1d ago
Elevance Health (ELV) Is Up 2.73% in One Week: What You Should KnowDoes Elevance Health (ELV) have what it takes to be a top stock pick for momentum investors? Let's find out.
Why ELV Stock advanced +1.84% Today — RQD Quant Desk Flash
$422.02 +1.84% NYSE • Public Delayed / 60s Snapshot
Elevance Health Inc. (ELV) carries a Roarable Rating of C- (Hold) with 61/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
ROARABLE C- • HOLD / WATCH
Cap $91.18B
INTERACTIVE SCENARIO DECK:
RQD QUANT TACHOMETERHOLD / WATCH • C-
JEV AI Jury Split (Battleground)
Cash
SEC
Whale
5-PILLAR SNOWFLAKE RADARRw D+ · Rk B
Each axis scored 0–20
12M PRICE TARGET CONE+1.4% Base Target
WHALE OPTIONS TUG-OF-WAR:61% Call Buyers ($9.9M)
39% PutsMax Pain: $414.00
AUTOMATED RQD QUANT DESK MOVER BRIEFINGFull Market News Desk →
Why ELV Stock advanced +1.84% Today — RQD Quant Desk Flash
Elevance Health Inc. (ELV) advanced +1.84% to $422.02 as options desks priced 61% call premium vs. 39% put protection around the $414 max-pain magnet. Solid 89% profit margin (9% return on capital), mixed timing at 16x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 84% of its 52-week range ($274.84 – $450.69) with RSI-14 at 50.8 (NEUTRAL RANGE).
- ▸Whale Options Positioning: $9.9M in bullish call flow vs. $6.5M in put flow (Put/Call 0.65x, implied earnings swing ±7.1%).
- ▸Fundamental Anchor: Roarable C- (Hold) backed by 89.4% gross margin and $3.2B annual free cash flow.
Live ELV Headlines & Catalysts
CATALYSTYahoo • 2d ago
THC Q3 Earnings Beat on Hospital Strength, 2026 EPS View RaisedTenet Healthcare's Q3 earnings surge 79.5% on strong hospital performance and cost discipline, prompting higher 2026 EPS and EBITDA guidance.
MARKET WIREYahoo • 3d ago
AxoGen, Inc. Q3 2026 Earnings Call SummaryMoby summary of AxoGen, Inc.'s Q3 2026 earnings call
MARKET WIREBenzinga • 3d ago
Elevance Health Files Prospectus For Mixed Shelf Offering; Terms Not Disclosedhttps://www.sec.gov/Archives/edgar/data/1156039/000119312526436231/d165308ds3asr.htm
CATALYSTYahoo • 3d ago
BSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock DownBoston Scientific's third-quarter revenues beat estimates, but contracting margins, weaker segment sales and reduced 2026 guidance weigh on shares.
MARKET WIREYahoo • 3d ago
Molina Healthcare (MOH) vs. ELV and UNH: Can Margin Recovery and Acquisitions Unlock Long-Term Upside?Is MOH a good stock to buy? We came across a bullish thesis on Molina Healthcare, Inc. on Valueinvestorsclub.com by banjo1055. Since the thesis was published on June 6th, MOH shares have pulled back as lower membership a
MARKET WIREBenzinga • 4d ago
'Drug Middlemen Will Soon Have to Share Details on How They Are Paid; New Labor Department regulation will require pharmacy-benefit managers to disclose information to employers' - WSJ Exclusivehttps://www.wsj.com/health/healthcare/drug-middlemen-will-soon-have-to-share-details-on-how-they-are-paid-9dd31447
MARKET WIREYahoo • 4d ago
3 US Health Insurance Stocks Built For Higher Interest RatesInterest rates that stay higher for longer change the rules. Cash is no longer free, debt-heavy stories look more fragile, and companies with solid balance sheets and dependable cash flow can quietly gain the upper hand.
CATALYSTYahoo • 4d ago
1 safe-and-steady stock with solid fundamentals and 2 we brush offLow-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.
CATALYSTBenzinga • 4d ago
Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $492Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $473 to $492.
🔴 SUNDAY NIGHT PREP • 7:00 PM ETHosted Live by Perry Belcher & Guest Trading Systems Desk
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live ELV Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
RQD INSIDER CLUB UPGRADE$49/YEAR
Want Plain-English AI Custom Indicators, Daily Pro Trader Video Clips & SMS Crash Alerts?
ELV // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +11.60%▲ ASCENDING CHANNEL
2026-10-30O $425.0H $426.8L $416.5C $420.1VOL 1.29M
RES: $452.1SUP: $381.6SMA50: $410.6SMA200: $372.4
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK
ELV Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Share Count & Dilution Monitor (#25)
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
Reverse-DCF Expectations Hurdle (#30)
8.7%/yr Implied 5Y Growth
vs. +12.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
Ellis Vennor Setup Ledger (#33)
No active Ellis Vennor swing setup published on ELV today. View full Setup Ledger →
🦋 Documented & Second-Order Butterfly Connections
Open Graph →
No direct multi-tier Butterfly edges indexed yet for ELV. Explore sector supply chains on /butterfly.
AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for ELV today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
ELV Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is ELV stock moving today?
Why ELV Stock advanced +1.84% Today — RQD Quant Desk Flash. Solid 89% profit margin (9% return on capital), mixed timing at 16x P/E—hold if owned, no rush to chase.